Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - STOCK-BASED COMPENSATION
Stock-based Compensation ENTA - Enanta Pharmaceuticals, Inc.
26.8 M
LAST VALUE
-0.32%
2 YEAR CAGR
6.86%
5 YEAR CAGR
25.88%
10 YEAR CAGR